FDA Inspection 1107470 — Neelakantan Anand, MD

Neelakantan Anand, MD — FEI 3015533953

The FDA completed an inspection of Neelakantan Anand, MD on October 24, 2019 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 24, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
297421 CFR 812.110(b)Investigator non-compliance with agreement/plan/regulations